Latest News
The Inflation Reduction Act’s Medicare Drug Price Negotiation Program updated
The Inflation Reduction Act of 2022 included several provisions to lower Medicare drug costs by requiring the Secretary of Health and Human Services (HHS) to negotiate prices with drug companies for certain drugs covered under Medicare Part D. Juliette Cubanski for The Kaiser Family Foundation has published a FAQ about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. Click here to be redirected to this article.
The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or socialsecurityreport.org.